Penetrium Bioscience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 2, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	575,563	69,801	44,182	43,575	129,707	-
Market Cap Growth	649.49%	57.99%	1.39%	-66.41%	-	-
Enterprise Value	578,814	67,834	29,262	15,150	100,632	-
Last Close Price	10510.00	1677.00	969.00	1030.00	2970.00	-
PE Ratio	-	-	-	163.51	67.47	-
PS Ratio	59.06	7.16	3.20	2.93	9.28	-
PB Ratio	86.83	10.53	1.30	1.18	3.84	-
P/TBV Ratio	87.39	10.60	1.70	1.48	3.87	-
P/OCF Ratio	-	-	-	48.22	188.20	-
EV/Sales Ratio	59.40	6.96	2.12	1.02	7.20	-
EV/EBITDA Ratio	-	-	-	45.78	36.04	-
EV/EBIT Ratio	-	-	-	-	48.14	-
Debt / Equity Ratio	1.40	1.40	0.02	0.02	0.01	0.02
Debt / EBITDA Ratio	-	-	-	1.94	0.12	0.08
Debt / FCF Ratio	-	-	-	-	-	0.07
Net Debt / Equity Ratio	0.52	0.52	-0.54	-0.93	-0.90	-0.98
Net Debt / EBITDA Ratio	-0.24	-0.24	51.88	-104.03	-10.90	-3.53
Net Debt / FCF Ratio	-0.24	-0.24	1.18	67.13	79.17	-2.74
Asset Turnover	0.27	0.27	0.31	0.35	0.47	0.71
Inventory Turnover	-	-	13.55	34.85	54.23	-
Quick Ratio	0.35	0.35	2.48	4.52	7.43	2.65
Current Ratio	0.55	0.55	3.05	5.07	8.47	3.35
Return on Equity (ROE)	-88.95%	-88.95%	-5.16%	-0.17%	7.13%	27.79%
Return on Assets (ROA)	-27.48%	-27.48%	-2.64%	-1.11%	4.42%	11.87%
Return on Invested Capital (ROIC)	-180.36%	-123.77%	-20.94%	19.99%	91.24%	249.09%
Return on Capital Employed (ROCE)	-200.40%	-200.40%	-5.30%	-2.00%	6.10%	23.40%
Earnings Yield	-3.49%	-28.79%	-6.72%	0.61%	1.48%	-
FCF Yield	-2.49%	-20.55%	-35.11%	-1.18%	-0.30%	-
Buyback Yield / Dilution	-	-	6.34%	-13.32%	-15.87%	-8.84%

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.